<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0214081</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-29792</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Insulin resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Insulin resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Insulin resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Diabetic endocrinology</subject><subj-group><subject>Insulin</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Insulin</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject><subj-group><subject>Adipokines</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject><subj-group><subject>Adipokines</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject><subj-group><subject>Adipokines</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject><subj-group><subject>Adipokines</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Molecular development</subject><subj-group><subject>Cytokines</subject><subj-group><subject>Adipokines</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Peptide hormones</subject><subj-group><subject>Adiponectin</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Age groups</subject><subj-group><subject>Children</subject><subj-group><subject>Adolescents</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Population groupings</subject><subj-group><subject>Families</subject><subj-group><subject>Children</subject><subj-group><subject>Adolescents</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Homeostasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Homeostasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Carbohydrates</subject><subj-group><subject>Monosaccharides</subject><subj-group><subject>Glucose</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject><subj-group><subject>Obesity</subject><subj-group><subject>Childhood obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological parameters</subject><subj-group><subject>Body weight</subject><subj-group><subject>Obesity</subject><subj-group><subject>Childhood obesity</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Probability theory</subject><subj-group><subject>Probability distribution</subject><subj-group><subject>Normal distribution</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Homeostatic model assessment of adiponectin (HOMA-Adiponectin) as a surrogate measure of insulin resistance in adolescents: Comparison with the hyperglycaemic clamp and homeostatic model assessment of insulin resistance</article-title>
<alt-title alt-title-type="running-head">HOMA-Adiponectin as a surrogate measure of insulin resistance</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5503-9533</contrib-id>
<name name-style="western">
<surname>da Silva</surname>
<given-names>Cleliani de Cassia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Zambon</surname>
<given-names>Mariana Porto</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Vasques</surname>
<given-names>Ana Carolina Junqueira</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Camilo</surname>
<given-names>Daniella Fernandes</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>De Bernardi Rodrigues</surname>
<given-names>Ana Maria</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7290-7950</contrib-id>
<name name-style="western">
<surname>Antonio</surname>
<given-names>Maria Ângela Reis de Góes Monteiro</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Dâmaso</surname>
<given-names>Ana Raimunda</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tufik</surname>
<given-names>Sergio</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>de Mello</surname>
<given-names>Marco Tulio</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Campos</surname>
<given-names>Raquel Munhoz da Silveira</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Geloneze</surname>
<given-names>Bruno</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<collab>for the Brazilian Metabolic Syndrome Study (BRAMS) Investigators</collab>
<xref ref-type="fn" rid="fn001"><sup>¶</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Laboratory of Investigation on Metabolism and Diabetes (Limed), Gastroenterological Diagnosis and Research Center (Gastrocentro), University of Campinas - Unicamp, Campinas, São Paulo, Brazil</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Postgraduate Program in Child and Adolescent Health, Faculty of Medical Sciences, University of Campinas - Unicamp, Campinas, São Paulo, Brazil</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Pediatrics, University of Campinas - Unicamp, Campinas, São Paulo, Brazil</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>School of Applied Sciences, University of Campinas - Unicamp, Limeira, São Paulo, Brazil</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>School of Health and Life Sciences, University Center Our Lady of Patronage, Itu, São Paulo, Brazil</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Postgraduate Program of Nutrition, Federal University of São Paulo - Unifesp, São Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Department of Psychobiology, Federal University of São Paulo - Unifesp, São Paulo, São Paulo, Brazil</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>School of Physical Education, Physiotherapy and Occupational Therapy, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>Department of Physiotherapy, Therapeutic Resources Laboratory, Federal University of São Carlos - UFSCar, São Carlos, São Paulo, Brazil</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Beyerlein</surname>
<given-names>Andreas</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Helmholtz Zentrum München, GERMANY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="other" id="fn001">
<p>¶ Membership of the Brazilian Metabolic Syndrome Study (BRAMS) Investigators is provided in the Acknowledgments.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">ccsnutri@yahoo.com.br</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>14</volume>
<issue>3</issue>
<elocation-id>e0214081</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>da Silva et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0214081"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Studies on adults have reported inverse association between the homeostatic model assessment (HOMA) of adiponectin (HOMA-Adiponectin) and the insulin resistance assessed by the glucose clamp technique. To our knowledge, in the pediatric population this association has not been previously investigated.</p>
</sec>
<sec id="sec002">
<title>Objectives</title>
<p>To evaluate the association between the HOMA-Adiponectin and the insulin resistance assessed by the glucose clamp technique in adolescents, and to compare the accuracy of HOMA-Adiponectin and HOMA-insulin resistance (HOMA-IR) for identifying insulin resistance.</p>
</sec>
<sec id="sec003">
<title>Methods</title>
<p>This was a cross-sectional study of 56 adolescents (aged 10–18 years). Insulin resistance was assessed using the HOMA-IR, HOMA-Adiponectin and the hyperglycaemic clamp technique. The clamp-derived insulin sensitivity index, HOMA-Adiponectin, and HOMA-IR were log-transformed to get closer to a normal distribution before analysis.</p>
</sec>
<sec id="sec004">
<title>Results</title>
<p>In the multivariable linear regression analysis controlling for sex and Tanner stage, HOMA-Adiponectin was inversely associated with the clamp-derived insulin sensitivity index (unstandardized coefficient [B] = -0.441; <italic>P</italic> &lt; 0.001). After additional adjustment for waist circumference-to-height ratio, this association remained significant (B = -0.349; <italic>P</italic> = &lt; 0.001). Similar results were observed when HOMA-IR replaced HOMA-Adiponectin in the model (B = -1.049 and B = -0.968 after additional adjustment for waist circumference-to-height ratio); all <italic>P</italic> &lt; 0.001. The area under the receiver operating characteristic curve for predicting insulin resistance was 0.712 (<italic>P</italic> = 0.02) for HOMA-Adiponectin and 0.859 (<italic>P</italic> &lt; 0.0001) HOMA-IR.</p>
</sec>
<sec id="sec005">
<title>Conclusions</title>
<p>The HOMA-Adiponectin was independently associated with insulin resistance and exhibited a good discriminatory power for predicting it. However, it did not show superiority over HOMA-IR in the diagnostic accuracy.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>National Council for Scientific and Technological Development (CNPq)</institution>
</funding-source>
<award-id>563664/2010-0</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Geloneze</surname>
<given-names>Bruno</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>São Paulo Research Foundation (FAPESP)</institution>
</funding-source>
<award-id>#2013/21476-3</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5503-9533</contrib-id>
<name name-style="western">
<surname>da Silva</surname>
<given-names>Cleliani de Cassia</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This study was funded by the National Council for Scientific and Technological Development (CNPq), grant number 563664/2010-0 (BG), and CCS was supported by a doctoral grant from the São Paulo Research Foundation (FAPESP), grant number #2013/21476-3 (<ext-link ext-link-type="uri" xlink:href="http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&amp;q2=id_pesquisador_exact%3A671472+AND+bolsa_exact%3A%22Bolsas+no+Brasil%22+AND+situacao_exact%3A%22Conclu%C3%ADdos%22" xlink:type="simple">http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&amp;q2=id_pesquisador_exact%3A671472+AND+bolsa_exact%3A%22Bolsas+no+Brasil%22+AND+situacao_exact%3A%22Conclu%C3%ADdos%22</ext-link>). The funders had no role in the design and implementation of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The opinions, assumptions, and conclusions or recommendations expressed in this material are the responsibility of the authors and do not necessarily reflect the views of the São Paulo Research Foundation (FAPESP) and of the National Council for Scientific and Technological Development (CNPq).</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<page-count count="12"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec006" sec-type="intro">
<title>Introduction</title>
<p>The fasting homeostatic model assessment of insulin resistance (HOMA-IR) [<xref ref-type="bibr" rid="pone.0214081.ref001">1</xref>] has been used as a surrogate measure of insulin resistance for epidemiological studies in pediatric populations and it assumes that hepatic and peripheral insulin resistance are equal. In 2007, HOMA-Adiponectin was proposed as a surrogate measure of insulin resistance in Japanese adults [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>]. Adiponectin levels are reduced in obese and negatively associated with insulin resistance in children and adolescents [<xref ref-type="bibr" rid="pone.0214081.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0214081.ref005">5</xref>]. The inclusion of total serum adiponectin level in the denominator of the HOMA-IR may add an indirect measurement of adiposopathy [<xref ref-type="bibr" rid="pone.0214081.ref006">6</xref>] and, consequently, indirect information of peripheral insulin resistance, giving robustness to its pathophysiological basis.</p>
<p>Studies on adults have reported inverse association between the HOMA-Adiponectin and the insulin resistance assessed by the glucose clamp technique [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0214081.ref006">6</xref>]. To our knowledge, in the pediatric population this association has not been previously investigated. Therefore, the purpose of the present study was to evaluate the association between HOMA-Adiponectin and insulin resistance assessed by the glucose clamp technique in adolescents, and to compare the accuracy of HOMA-Adiponectin and HOMA-IR for identifying insulin resistance.</p>
</sec>
<sec id="sec007" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec008">
<title>Study population and design</title>
<p>This study used data from the Brazilian Metabolic Syndrome Study (BRAMS). All information of the BRAMS Study have previously been described in detail [<xref ref-type="bibr" rid="pone.0214081.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0214081.ref008">8</xref>]. In brief, BRAMS is a cross-sectional multicenter study that included an intentional non-probabilistic sample of adolescents (10 to 19 years and 11 months) recruited from the Clinic of Obesity in Children and Adolescents at Clinical Hospital of University of Campinas, from the São Paulo Hospital of Federal University of São Paulo, and from the Health Units, public schools and institutions offering educational programs for adolescents. In 2011–2015, about 1033 adolescents were examined. From this cohort, 82 adolescents (10–18 years old) underwent the hyperglycaemic clamp technique. Of the 1033 enrolled participants in the BRAMS study, 630 had valid data for the explanatory variable of interest, HOMA-Adiponectin. Of the 82 adolescents underwent the hyperglycaemic clamp technique, 56 had valid data for the explanatory variable of interest. <xref ref-type="fig" rid="pone.0214081.g001">Fig 1</xref> presents the flow diagram of the study population. Adolescents were eligible to participate if they had a body mass index (BMI) for age and sex at or above the fifth percentile according to the Centers for Disease Control and Prevention growth charts [<xref ref-type="bibr" rid="pone.0214081.ref009">9</xref>]. Adolescents with metabolic disorders (e.g., hypothyroidism, hyperthyroidism, or type 1 and type 2 diabetes), nephropathy, hepatopathy, genetic syndrome, delayed neuropsychomotor development, malnutrition, pregnant or in treatment with systemic corticosteroids and drugs with hypoglycaemic and hypolipidemic properties were not included in the study.</p>
<fig id="pone.0214081.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0214081.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram describing the selection of the study population.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.g001" xlink:type="simple"/>
</fig>
<p>The study was approved by the Ethics Committee of the Faculty of Medical Sciences of University of Campinas (protocol number 900/2010) and conducted in accordance to the Declaration of Helsinki. Written informed consent was obtained from parents.</p>
</sec>
<sec id="sec009">
<title>Data collection methods</title>
<p>Sexual maturation was self-evaluated [<xref ref-type="bibr" rid="pone.0214081.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0214081.ref011">11</xref>] according to Tanner criteria [<xref ref-type="bibr" rid="pone.0214081.ref012">12</xref>] and the participants were classified as pubertal (Tanner II-IV) and postpubertal (Tanner V). BMI was calculated as weight in kilograms divided by height in meters squared. BMI-for-age percentile were calculated for each adolescent using Epi Info version 3.5.2 (Centers for Disease Control and Prevention, Atlanta, GA, USA). The nutritional status was classified as normal weight (BMI-for-age between the 5th percentile and the 85th percentile); overweight (BMI-for-age between 85th percentile and the 95th percentile); and obesity (BMI-for-age at or above the 95th percentile) according to the Centers for Disease Control and Prevention criteria (CDC/2000) [<xref ref-type="bibr" rid="pone.0214081.ref009">9</xref>]. Waist circumference was measured directly over the skin, at the midpoint between the lower margin of the last palpable rib and the top of the iliac crest (hip bone), at the end of a normal expiration [<xref ref-type="bibr" rid="pone.0214081.ref013">13</xref>]. Waist circumference-to-height ratio was calculated as the waist circumference (in cm) divided by height (in cm). Lean body mass was estimated by tetrapolar bioimpedance (Biodynamics, model 310, Shoreline, WA, USA). Laboratory assays included plasma glucose (enzymatic colorimetric methods; monoreagent K082, Bioclin Systems II, Quisaba, Bioclin, Belo Horizonte, MG, Brazil), plasma insulin (human insulin enzyme-linked immunosorbent assay kit—EZHI-14K; Millipore, USA; sensitivity: 2 μU/mL; intra-assay coefficients of variation: 4.6–7.0%; inter-assay coefficients of variation: 9.1–11.4%), and the quantitative determination of serum concentrations of total adiponectin (Quantikine Human Adiponectin/Acrp30 ELISA kit; R&amp;D Systems, Inc., Minneapolis, MN; intra-assay coefficients of variation: 2.5–4.7%; inter-assay coefficients of variation: 6.8–6.9%). Insulin resistance was assessed using the HOMA-IR (calculated as the product of the fasting plasma insulin level [in milliunits per liter] and the fasting plasma glucose level [in millimoles per liter], divided by the 22.5) [<xref ref-type="bibr" rid="pone.0214081.ref001">1</xref>], HOMA-Adiponectin (calculated as the product of the fasting plasma insulin level [in milliunits per liter] and the fasting plasma glucose level [in millimoles per liter], divided by the adiponectin level [in microgram per milliliter]) [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>], and the 120-min. hyperglycaemic clamp technique [<xref ref-type="bibr" rid="pone.0214081.ref014">14</xref>]. The clamp-derived insulin sensitivity index (ISI) was calculated as the mean exogenous glucose infusion rate from 60–120 minutes of the clamp technique minus urinary glucose excretion, divided by the mean insulin concentration of five determinations during the same time period, and was corrected for lean body mass (LBM) [ISI<sub>LBM</sub>; milligrams of glucose infused per kilogram of lean body mass per minute, multiplied by 100) [<xref ref-type="bibr" rid="pone.0214081.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0214081.ref015">15</xref>].</p>
</sec>
<sec id="sec010">
<title>Statistical analysis</title>
<p>The data (<xref ref-type="supplementary-material" rid="pone.0214081.s001">S1 File</xref>) were analyzed using MedCalc for Windows, version 17.9.7 (MedCalc Software, Ostend, Belgium), and the IBM SPSS Statistics for Windows, version 20.0 (IBM Corporation, Armonk, NY, USA). A <italic>P</italic>-value less than 0.05 was considered statistically significant. The Shapiro-Wilk test was used to evaluate the variables distribution and clamp-derived insulin sensitivity index, HOMA-Adiponectin and HOMA-IR were log-transformed to get closer to a normal distribution. Continuous variables with normal distribution were expressed as mean ± standard deviation, whereas non-normally distributed variables were expressed as median (interquartile ranges). Qualitative data were presented as percentages. Fisher’s exact test was used to compare two proportions. Comparisons of two independent groups were performed using Student’s t-test for groups with normally distributed data, and Mann-Whitney U test for groups with not normally distributed data. Pearson’s correlation coefficient was used to analyze the relationship between two continuous variables. Multiple linear regression analysis was used to examine the associations between clamp-derived insulin sensitivity index (dependent variable) and the HOMA-Adiponectin or HOMA-IR (independent variables). The HOMA-Adiponectin and HOMA-IR were not assessed simultaneously in the regression model because the statistics indicated a multicollinearity problem (variance inflation factor higher than 2 [<xref ref-type="bibr" rid="pone.0214081.ref016">16</xref>], and proportions of variance higher than 0.45 [<xref ref-type="bibr" rid="pone.0214081.ref017">17</xref>]). Like previous studies have shown significant differences in insulin resistance between boys and girls [<xref ref-type="bibr" rid="pone.0214081.ref018">18</xref>]; and that insulin resistance increases significantly at Tanner stage 2, 3, and 4, but decreases to near prepubertal levels at Tanner stage 5 [<xref ref-type="bibr" rid="pone.0214081.ref018">18</xref>]; and that increased abdominal visceral adiposity in obese adolescent is associated with lower insulin sensitivity [<xref ref-type="bibr" rid="pone.0214081.ref019">19</xref>], we included sex, Tanner stage and waist circumference-to-height ratio (a measure of abdominal adiposity) [<xref ref-type="bibr" rid="pone.0214081.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0214081.ref021">21</xref>], as independent variables in the regression models. Receiver operating characteristic (ROC) analysis was used to evaluate accuracy of the HOMA-Adiponectin for detecting insulin resistance, as evaluated by hyperglycaemic clamp technique, and to compare the diagnostic accuracy of HOMA-Adiponectin versus the HOMA-IR. A comparison between areas under the ROC curve (AUC) was performed, and the method of DeLong et al [<xref ref-type="bibr" rid="pone.0214081.ref022">22</xref>] was used for the calculation of the standard error of the AUCs and of the difference between the two AUCs. Insulin resistance was defined based on cutoff of clamp-derived insulin sensitivity index (lower 10th percentile) derived from the normal-weight group (cutoff, &lt; 0.07 mg/kg<sub>LBM</sub>/min per mU/L x 100). The <xref ref-type="supplementary-material" rid="pone.0214081.s002">S2 File</xref> contains all analysis codes.</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<p>Overweight/obese adolescents had higher plasma glucose, plasma insulin, HOMA-Adiponectin and HOMA-IR, compared with those with normal weight. Moreover, they had lower adiponectin and clamp-derived insulin sensitivity index compared with those with normal weight (<xref ref-type="table" rid="pone.0214081.t001">Table 1</xref>).</p>
<table-wrap id="pone.0214081.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0214081.t001</object-id>
<label>Table 1</label> <caption><title>Participant characteristics.</title></caption>
<alternatives>
<graphic id="pone.0214081.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Variables</th>
<th align="center">Normal weight<break/>(n = 22)</th>
<th align="center">Overweight/obese<break/>(n = 34)</th>
<th align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Age, years</td>
<td align="center">15.6 ± 2.3</td>
<td align="center">14.3 ± 2.2</td>
<td align="char" char=".">0.04<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="4">Sex, No. (%)</td>
</tr>
<tr>
<td align="left"> Female</td>
<td align="center">14 (63.6)</td>
<td align="center">15 (44.1)</td>
<td align="char" char="." rowspan="2">0.18<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left"> Male</td>
<td align="center">8 (36.4)</td>
<td align="center">19 (55.9)</td>
</tr>
<tr>
<td align="left" colspan="4">Tanner stage, No. (%)</td>
</tr>
<tr>
<td align="left"> Pubertal, Tanner II-IV</td>
<td align="center">6 (27.3)</td>
<td align="center">15 (44.1)</td>
<td align="char" char="." rowspan="2">0.26<xref ref-type="table-fn" rid="t001fn004"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="left"> Postpubertal, Tanner V</td>
<td align="center">16 (72.7)</td>
<td align="center">19 (55.9)</td>
</tr>
<tr>
<td align="left">Weight, kg</td>
<td align="center">52.5 (47.6 to 60.2)</td>
<td align="center">82.9 (73.0 to 90.1)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Height, cm</td>
<td align="center">161.0 ± 10.6</td>
<td align="center">165.0 ± 8.5</td>
<td align="char" char=".">0.124<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Body mass index, kg/m<sup>2</sup></td>
<td align="center">20.2 (18.8 to 22.8)</td>
<td align="center">28.9 (27.8 to 31.7)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Body mass index-for-age percentile</td>
<td align="center">60.4 (22.5 to 79.9)</td>
<td align="center">97.7 (96.1 to 98.7)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Waist circumference, cm</td>
<td align="center">70.0 (66.3 to 75.5)</td>
<td align="center">95.2 (90.0 to 103.5)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Waist circumference-to-height ratio</td>
<td align="center">0.44 (0.41 to 0.48)</td>
<td align="center">0.57 (0.53 to 0.63)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Lean body mass, kg</td>
<td align="center">39.6 (35.1 to 46.9)</td>
<td align="center">51.7 (48.0 to 61.6)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Adiponectin, μg/mL</td>
<td align="center">5.02 (2.85 to 7.56)</td>
<td align="center">2.44 (1.60 to 4.46)</td>
<td align="char" char=".">0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">Plasma glucose, mg/dL</td>
<td align="center">85 ± 6</td>
<td align="center">89 ± 6</td>
<td align="char" char=".">0.03<xref ref-type="table-fn" rid="t001fn003"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left">Plasma insulin, mU/L</td>
<td align="center">7.2 (4.8 to 10.3)</td>
<td align="center">12.0 (8.7 to 18.0)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">HOMA-Adiponectin</td>
<td align="center">6.64 (3.49 to 9.15)</td>
<td align="center">22.53 (9.79 to 59.77)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">HOMA-IR</td>
<td align="center">1.69 (0.96 to 1.99)</td>
<td align="center">2.63 (1.94 to 3.95)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
<tr>
<td align="left">ISI, mg/kg<sub>LBM</sub><sup>-1</sup>. min<sup>-1</sup> per mU/L x 100</td>
<td align="center">0.27 (0.16 to 0.42)</td>
<td align="center">0.09 (0.06 to 0.14)</td>
<td align="char" char=".">&lt; 0.001<xref ref-type="table-fn" rid="t001fn005"><sup>c</sup></xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Abbreviations: HOMA-Adiponectin, homeostasis model assessment of adiponectin; HOMA-IR, homeostasis model assessment of insulin resistance; ISI, insulin sensitivity index; LBM, lean body mass</p></fn>
<fn id="t001fn002"><p>SI conversion factors: To convert glucose to millimoles per liter, multiply by 0.0555; and to convert insulin to picomoles per liter, multiply by 6</p></fn>
<fn id="t001fn003"><p><sup>a</sup>Student’s t-test, data are presented as the mean ± standard deviation;</p></fn>
<fn id="t001fn004"><p><sup>b</sup>Fisher’s exact test, data are expressed as a percentage;</p></fn>
<fn id="t001fn005"><p><sup>c</sup>Mann-Whitney U test, data are presented as the median (interquartile ranges)</p></fn>
</table-wrap-foot>
</table-wrap>
<p>HOMA-Adiponectin and HOMA-IR were inversely correlated with the clamp-derived insulin sensitivity index (r = -0.662; <italic>P</italic> &lt; 0.001 and r = -0.799; <italic>P</italic> &lt; 0.001, respectively).</p>
<p>Multiple linear regression models are presented in <xref ref-type="table" rid="pone.0214081.t002">Table 2</xref>. In the first model that included HOMA-Adiponectin, sex and Tanner stage as the independent variables, HOMA-Adiponectin was inversely associated with the clamp-derived insulin sensitivity index (<italic>P</italic> &lt; 0.001). This model explained 47.1% of the variance in clamp-derived insulin sensitivity. The second model included HOMA-Adiponectin, sex, Tanner stage and waist circumference-to-height ratio as the independent variables. In this model, waist circumference-to-height ratio was inversely associated with the clamp-derived insulin sensitivity index (<italic>P</italic> = 0.026). The inclusion of waist circumference-to-height ratio in the model did not eliminate the inverse significant association between HOMA-Adiponectin and clamp-derived insulin sensitivity index (<italic>P</italic> &lt; 0.001). This model explained 52.1% of the variance in clamp-derived insulin sensitivity. The third model included HOMA-IR, sex and Tanner stage as independent variables. In this model, HOMA-IR was inversely associated with the clamp-derived insulin sensitivity index (<italic>P</italic> &lt; 0.001). This model explained 63.8% of the variance in clamp-derived insulin sensitivity and when we included the waist circumference-to-height ratio (fourth model), it did not increase this variance considerably (64.4%) neither changed the association of HOMA-IR with clamp-derived insulin sensitivity index (<italic>P</italic> &lt; 0.001).</p>
<table-wrap id="pone.0214081.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0214081.t002</object-id>
<label>Table 2</label> <caption><title>Multiple regression analysis of the HOMA-Adiponectin and HOMA-IR with clamp-derived insulin sensitivity index.</title></caption>
<alternatives>
<graphic id="pone.0214081.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Dependent variable</th>
<th align="center">Model</th>
<th align="center">Independent variables</th>
<th align="center">B</th>
<th align="center">95% CI</th>
<th align="center"><italic>P</italic>-value</th>
<th align="center"><italic>R</italic><sup>2</sup> for model</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="14">ISI, mg/kg<sub>LBM</sub><sup>-1</sup>. min<sup>-1</sup> per mU/L x 100<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref><sup>,</sup><xref ref-type="table-fn" rid="t002fn003"><sup>b</sup></xref></td>
<td align="center" rowspan="3">1</td>
<td align="left">HOMA-Adiponectin<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></td>
<td align="char" char=".">-0.441</td>
<td align="center">-0.581 to -0.300</td>
<td align="char" char=".">&lt; 0.001</td>
<td align="char" char="." rowspan="3">0.471</td>
</tr>
<tr>
<td align="left">Sex<xref ref-type="table-fn" rid="t002fn004"><sup>c</sup></xref></td>
<td align="char" char=".">0.083</td>
<td align="center">-0.065 to 0.231</td>
<td align="char" char=".">0.264</td>
</tr>
<tr>
<td align="left">Tanner stage<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">-0.122</td>
<td align="center">-0.276 to 0.032</td>
<td align="char" char=".">0.117</td>
</tr>
<tr>
<td align="center" rowspan="4">2</td>
<td align="left">HOMA-Adiponectin<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></td>
<td align="char" char=".">-0.349</td>
<td align="center">-0.506 to -0.192</td>
<td align="char" char=".">&lt; 0.001</td>
<td align="char" char="." rowspan="4">0.521</td>
</tr>
<tr>
<td align="left">Sex<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">0.123</td>
<td align="center">-0.23 to 0.269</td>
<td align="char" char=".">0.097</td>
</tr>
<tr>
<td align="left">Tanner stage<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">-0.125</td>
<td align="center">-0.273 to 0.023</td>
<td align="char" char=".">0.096</td>
</tr>
<tr>
<td align="left">Waist circumference-to-height ratio</td>
<td align="char" char=".">-1.018</td>
<td align="center">-1.907 to -0.128</td>
<td align="char" char=".">0.026</td>
</tr>
<tr>
<td align="center" rowspan="3">3</td>
<td align="left">HOMA-IR<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></td>
<td align="char" char=".">-1.049</td>
<td align="center">-1.282 to -0.817</td>
<td align="char" char=".">&lt; 0.001</td>
<td align="char" char="." rowspan="3">0.638</td>
</tr>
<tr>
<td align="left">Sex<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">-0.011</td>
<td align="center">-0.135 to 0.113</td>
<td align="char" char=".">0.856</td>
</tr>
<tr>
<td align="left">Tanner stage<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">0.008</td>
<td align="center">-0.125 to 0.142</td>
<td align="char" char=".">0.899</td>
</tr>
<tr>
<td align="center" rowspan="4">4</td>
<td align="left">HOMA-IR<xref ref-type="table-fn" rid="t002fn002"><sup>a</sup></xref></td>
<td align="char" char=".">-0.968</td>
<td align="center">-1.259 to -0.676</td>
<td align="char" char=".">&lt; 0.001</td>
<td align="char" char="." rowspan="4">0.644</td>
</tr>
<tr>
<td align="left">Sex<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">0.011</td>
<td align="center">-0.122 to 0.145</td>
<td align="char" char=".">0.867</td>
</tr>
<tr>
<td align="left">Tanner stage<xref ref-type="table-fn" rid="t002fn005"><sup>d</sup></xref></td>
<td align="char" char=".">-0.003</td>
<td align="center">-0.138 to 0.133</td>
<td align="char" char=".">0.968</td>
</tr>
<tr>
<td align="left">Waist circumference-to-height ratio</td>
<td align="char" char=".">-0.384</td>
<td align="center">-1.207 to 0.439</td>
<td align="char" char=".">0.353</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Abbreviations: B, unstandardized coefficient; CI, confidence interval; ISI, insulin sensitivity index; LBM, lean body mass; HOMA-Adiponectin, homeostasis model assessment of adiponectin; HOMA-IR, homeostasis model assessment of insulin resistance; NA, not applicable</p></fn>
<fn id="t002fn002"><p><sup>a</sup>Logarithmic transformation was performed.</p></fn>
<fn id="t002fn003"><p><sup>b</sup>Insulin sensitivity index (ISI) expressed as milligrams of glucose infused per kilogram of lean body mass (LBM) per minute.</p></fn>
<fn id="t002fn004"><p><sup>c</sup>0 represents the female and 1 the male.</p></fn>
<fn id="t002fn005"><p><sup>d</sup>0 represents the postpubertal stage and 1 the pubertal stage</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The ROC curves of HOMA-Adiponectin and HOMA-IR in the detection of insulin resistance were presented in <xref ref-type="fig" rid="pone.0214081.g002">Fig 2</xref>. Both HOMA-Adiponectin (AUC: 0.712; 95% confidence interval [95CI%]: 0.576–0.825; <italic>P</italic> = 0.02) and HOMA-IR (AUC: 0.859; 95CI%: 0.740–0.937; <italic>P</italic> &lt; 0.0001) presented good discriminatory power for the detection of insulin resistance. The AUC of HOMA-IR was significantly higher compared with HOMA-Adiponectin (difference between areas: 0.147; 95%CI: 0.042 to 0.251; <italic>z</italic> statistic: 2.766; <italic>P</italic> = 0.005).</p>
<fig id="pone.0214081.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0214081.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Receiver operating characteristic curves of the HOMA-Adiponectin and HOMA-IR for detecting insulin resistance.</title>
<p>The dashed line represents the HOMA-IR (homeostasis model assessment of insulin resistance), and solid line represents the HOMA-Adiponectin (homeostasis model assessment of adiponectin). The solid grey line is the reference and it represents an AUC of 0.5.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>To our knowledge, this is the first study in adolescents to examine the accuracy of HOMA-Adiponectin in detecting insulin resistance based on hyperglycaemic clamp technique. The main findings of our study are: 1) HOMA-Adiponectin was inversely associated with clamp-derived insulin sensitivity, but the variance of the insulin sensitivity explained by it was not superior to HOMA-IR; and 2) the HOMA-Adiponectin could discriminate patients with and without insulin resistance, however, without a better discriminatory accuracy than HOMA-IR.</p>
<p>HOMA-IR [<xref ref-type="bibr" rid="pone.0214081.ref001">1</xref>] has been validated as a surrogate measure of insulin resistance in children and adolescents and is widely used in epidemiological studies in pediatric populations [<xref ref-type="bibr" rid="pone.0214081.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0214081.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0214081.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0214081.ref023">23</xref>]. However, it assumes that hepatic and peripheral insulin resistance are equal. The inclusion of total serum adiponectin level in the denominator of the HOMA-IR may add an indirect measurement of adiposopathy [<xref ref-type="bibr" rid="pone.0214081.ref006">6</xref>] and, consequently, indirect information of peripheral insulin resistance, giving robustness to its pathophysiological basis.</p>
<p>Adiponectin is a protein synthesized mainly in adipose tissue and secreted into the serum [<xref ref-type="bibr" rid="pone.0214081.ref024">24</xref>]. One of the hypotheses for insulin-sensitizing effect by adiponectin is the increase in fatty-acid oxidation in muscle and liver via activation of adenosine monophosphate activated protein kinase (AMPK) and of peroxisome proliferator-activated receptor-alpha (PPAR-α), mediated by adiponectin receptors (AdipoR1 mainly expressed in the skeletal muscle and AdipoR2 in the liver) [<xref ref-type="bibr" rid="pone.0214081.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0214081.ref026">26</xref>]. In adolescents, the positive association between adiponectin and insulin sensitivity has been well documented [<xref ref-type="bibr" rid="pone.0214081.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0214081.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0214081.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0214081.ref028">28</xref>], similar result was observed in the present study (r = 0.338; <italic>P</italic> = 0.01).</p>
<p>HOMA-Adiponectin was validated as a surrogate measure of insulin resistance in Japanese adults [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>], and consistent with our results, studies in adults have found an inverse correlation between the HOMA-Adiponectin and the clamp-derived insulin sensitivity [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0214081.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0214081.ref029">29</xref>]. However, contrary to what we observed, these studies reported a higher correlation coefficient for HOMA-Adiponectin when compared to HOMA-IR. In addition, in the multiple linear regression model, we observed that HOMA-Adiponectin was still associated with clamp-derived insulin sensitivity after adjustment for sex, Tanner stage and waist circumference-to-height ratio. In our data, however, the variance of the insulin sensitivity explained by the HOMA-Adiponectin was not superior to HOMA-IR. Contrary to what we observed, in a cross-sectional study of Japanese adults of both sexes, Matsuhisa et al. [<xref ref-type="bibr" rid="pone.0214081.ref002">2</xref>] observed that in the stepwise multivariate regression analysis the HOMA-Adiponectin was most significantly associated and independently with the clamp-derived insulin sensitivity (M-value calculated from euglycemic hyperinsulinemic clamp technique) than HOMA-IR. This disparity might be due to differences in populations studied (such as age and race/ethnicity), or methodological or in the statistical analyses.</p>
<p>Furthermore, the present study showed, for the first time, that HOMA-Adiponectin (AUC = 0.712) could discriminate patients with and without insulin resistance, however, without a better discriminatory accuracy than HOMA-IR (AUC = 0.859). In opposition with ours results, a Brazilian adult’s study, by our research group, showed a similar performance for HOMA-Adiponectin and HOMA-IR to identify insulin resistance [<xref ref-type="bibr" rid="pone.0214081.ref006">6</xref>]. The divergence in the results could be due to the group age, and to the criteria used for insulin resistance. In the present study, insulin resistance was defined based on cutoff of clamp-derived insulin sensitivity index (lower than the 10th percentile) derived from the normal-weight group.</p>
<p>Makni et al [<xref ref-type="bibr" rid="pone.0214081.ref030">30</xref>] in another cross-sectional study of obese children (mean age 13.7 ± 1.3 years), investigated the efficacy of HOMA-Adiponectin and HOMA-IR in assessing insulin resistance classified according to metabolic syndrome diagnosis. They reported an AUC of 0.71 (CI 95%: 0.62–0.79, <italic>P</italic> &lt; 0.05) for the HOMA-Adiponectin and of 0.68 (CI 95%: 0.59–0.76, <italic>P</italic> &lt; 0.01) for the HOMA-IR, and concluded that HOMA-Adiponectin is an adequate tool for determining insulin resistance among obese children with metabolic syndrome. However, the HOMA-Adiponectin was not compared with the glucose clamp technique, which is the reference method to assess insulin resistance.</p>
<p>Our results suggest that HOMA-Adiponectin could be used as a surrogate measure of insulin resistance in adolescents. However, we recommend the use of HOMA-IR in this age group since it presented better diagnostic accuracy than HOMA-Adiponectin in detecting insulin resistance. In addition, laboratory assays of plasma glucose and insulin are easier and cheaper to obtain than adiponectin measurement, which is not yet a routinely run test in public health service. Furthermore, previously, we have identified other more simple and practical methods, such as the waist circumference [<xref ref-type="bibr" rid="pone.0214081.ref008">8</xref>], sagittal abdominal diameter [<xref ref-type="bibr" rid="pone.0214081.ref008">8</xref>] and the hypertriglyceridemic waist phenotype (presence of a concomitant increase in plasma triglycerides and waist circumference) [<xref ref-type="bibr" rid="pone.0214081.ref007">7</xref>] that also can be used as surrogate measures of insulin resistance in this age group. The choice of the method will depend on the goals you are interested, research or clinical evaluation, the infrastructure available, the professional experience and the health service.</p>
<p>This study had some limitations. First, it is a cross-sectional study, so it does not allow causal inferences. Second, we used the hyperglycaemic clamp technique, not the gold standard, even because studies have reported a strong correlation between insulin sensitivity from this clamp technique and from the euglycaemic-hyperinsulinaemic clamp technique, the gold standard, in children and adolescents, with fewer side effects [<xref ref-type="bibr" rid="pone.0214081.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0214081.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0214081.ref032">32</xref>]. Third, sexual maturation was determined by self-assessment to increase the participation rate [<xref ref-type="bibr" rid="pone.0214081.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0214081.ref011">11</xref>], due to privacy concerns, cultural and emotional factors. Validation studies found reasonable agreement between self-assessed sexual maturation and physical examination performed by a physician in epidemiologic studies [<xref ref-type="bibr" rid="pone.0214081.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0214081.ref033">33</xref>], and suggest the self-assessed examination when the physician exam is not possible [<xref ref-type="bibr" rid="pone.0214081.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0214081.ref033">33</xref>]. In addition, Rasmussen et al [<xref ref-type="bibr" rid="pone.0214081.ref011">11</xref>] suggest that its use can be sufficiently accurate for a simple distinction between prepuberty and puberty for large epidemiologic studies. Fourth, we did not consider race/ethnicity because Brazilian people is one of the most admixture populations in the world.</p>
<p>In conclusion, our results showed that the HOMA-Adiponectin was independently associated with insulin resistance and exhibited a good discriminatory power for predicting it. However, it did not show superiority over HOMA-IR in the diagnostic accuracy.</p>
</sec>
<sec id="sec013">
<title>Supporting information</title>
<supplementary-material id="pone.0214081.s001" mimetype="application/vnd.ms-excel" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.s001" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>BRAMS dataset.</title>
<p>In this part, we presented the dataset used for the statistical analyses. Participants were classified as pubertal (Tanner II-IV) and postpubertal (Tanner V) according to Tanner criteria [<xref ref-type="bibr" rid="pone.0214081.ref012">12</xref>]. The nutritional status was classified as normal weight (BMI-for-age at or above the 5th percentile and below the 85th percentile); overweight (BMI-for-age at or above the 85th percentile and below the 95th percentile); and obesity (BMI-for-age at or above the 95th percentile) according to the Centers for Disease Control and Prevention criteria (CDC/2000) [<xref ref-type="bibr" rid="pone.0214081.ref009">9</xref>].</p>
<p>(XLS)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0214081.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0214081.s002" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>Analysis codes.</title>
<p>In this part, we presented the codes for each statistical test.</p>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Names of the members of the Brazilian Metabolic Syndrome Study (BRAMS) Investigators group (in alphabetical order):</p>
<p>Ana Carolina Junqueira Vasques—University of Campinas, Brazil</p>
<p>Ana Maria De Bernardi Rodrigues—University of Campinas, Brazil</p>
<p>Ana Raimunda Dâmaso—Federal University of São Paulo—Unifesp, Brazil</p>
<p>Arnandra Nichaela Biill Alves—University of Campinas, Brazil</p>
<p>Bruna Dyane Sitta—University of Campinas, Brazil</p>
<p><bold>Bruno Geloneze—University of Campinas, Brazil (The lead author for this group—email address</bold>: <email xlink:type="simple">bgeloneze@terra.com.br</email><bold>)</bold></p>
<p>Camila Inajara Caturani de Araujo—University of Campinas, Brazil</p>
<p>Cleliani de Cassia da Silva—University of Campinas, Brazil</p>
<p>Daniella Fernandes Camilo—University of Campinas, Brazil</p>
<p>Fabiana Lopes Nogueira—University of Campinas, Brazil</p>
<p>Francieli Barreiro-Ribeiro—University of Campinas, Brazil</p>
<p>José Carlos Pareja—University of Campinas, Brazil</p>
<p>Leandra Giorgetti dos Santos—University of Campinas, Brazil</p>
<p>Marco Túlio de Mello—Federal University of Minas Gerais, Brazil</p>
<p>Maria Ângela Reis de Góes Monteiro Antonio—University of Campinas, Brazil</p>
<p>Mariana da Silva Oliveira—University of Campinas, Brazil</p>
<p>Mariana Pontes Ferrari—University of Campinas, Brazil</p>
<p>Mariana Porto Zambon—University of Campinas, Brazil</p>
<p>Mayra Mello—University of Campinas, Brazil</p>
<p>Patrícia Brito Rodrigues—University of Campinas, Brazil</p>
<p>Raquel Munhoz da Silveira Campos—Federal University of São Carlos—UFSCar, Brazil</p>
<p>Roberta Soares Lara Cassani—University of Campinas, Brazil</p>
<p>Sergio Tufik—Federal University of São Paulo—Unifesp, Brazil</p>
<p>Stela Caroline Rodrigues de Meira—University of Campinas, Brazil</p>
<p>Vanessa Cristine Rugolo—University of Campinas, Brazil</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0214081.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matthews</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Hosker</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Rudenski</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Naylor</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Treacher</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>RC</given-names></name>. <article-title>Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man</article-title>. <source>Diabetologia</source>. <year>1985</year>;<volume>28</volume>(<issue>7</issue>):<fpage>412</fpage>–<lpage>419</lpage>. <object-id pub-id-type="pmid">3899825</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matsuhisa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yamasaki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Emoto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Shimabukuro</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ueda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Funahashi</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2007</year>;<volume>77</volume>(<issue>1</issue>):<fpage>151</fpage>–<lpage>154</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.diabres.2006.10.005" xlink:type="simple">10.1016/j.diabres.2006.10.005</ext-link></comment> <object-id pub-id-type="pmid">17081646</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weiss</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dziura</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Burgert</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Tamborlane</surname> <given-names>WV</given-names></name>, <name name-style="western"><surname>Taksali</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Yeckel</surname> <given-names>CW</given-names></name>, <etal>et al</etal>. <article-title>Obesity and the metabolic syndrome in children and adolescents</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>(<issue>23</issue>):<fpage>2362</fpage>–<lpage>2374</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa031049" xlink:type="simple">10.1056/NEJMoa031049</ext-link></comment> <object-id pub-id-type="pmid">15175438</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bacha</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Saad</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gungor</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>AS</given-names></name>. <article-title>Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function</article-title>. <source>Diabetes Care</source>. <year>2004</year>;<volume>27</volume>(<issue>2</issue>):<fpage>547</fpage>–<lpage>552</lpage>. <object-id pub-id-type="pmid">14747242</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bacha</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Gungor</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>SA</given-names></name>. <article-title>Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity</article-title>. <source>Diabetes Care</source>. <year>2006</year>;<volume>29</volume>(<issue>1</issue>):<fpage>51</fpage>–<lpage>56</lpage>. <object-id pub-id-type="pmid">16373895</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vilela</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Vasques</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Cassani</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Forti</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Pareja</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Tambascia</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>The HOMA-Adiponectin (HOMA-AD) closely mirrors the HOMA-IR index in the screening of insulin resistance in the Brazilian Metabolic Syndrome Study (BRAMS)</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>8</issue>):<fpage>e0158751</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0158751" xlink:type="simple">10.1371/journal.pone.0158751</ext-link></comment> <object-id pub-id-type="pmid">27490249</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barreiro-Ribeiro</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Vasques</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>da Silva</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Zambon</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Rodrigues</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Camilo</surname> <given-names>DF</given-names></name>, <etal>et al</etal>. <article-title>Hypertriglyceridemic waist phenotype indicates insulin resistance in adolescents according to the clamp technique in the BRAMS study</article-title>. <source>Child Obes</source>. <year>2016</year>;<volume>12</volume>(<issue>6</issue>):<fpage>446</fpage>–<lpage>454</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/chi.2016.0180" xlink:type="simple">10.1089/chi.2016.0180</ext-link></comment> <object-id pub-id-type="pmid">27627113</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>da Silva</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Vasques</surname> <given-names>ACJ</given-names></name>, <name name-style="western"><surname>Zambon</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Camilo</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>De Bernardi Rodrigues</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Antonio</surname> <given-names>MÂRGM</given-names></name>, <etal>et al</etal>. <article-title>Sagittal abdominal diameter resembles waist circumference as a surrogate marker of insulin resistance in adolescents-Brazilian Metabolic Syndrome Study</article-title>. <source>Pediatr Diabetes</source>. <year>2018</year>;<volume>19</volume>(<issue>5</issue>):<fpage>882</fpage>–<lpage>891</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/pedi.12664" xlink:type="simple">10.1111/pedi.12664</ext-link></comment> <object-id pub-id-type="pmid">29573519</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuczmarski</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Ogden</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Grummer-Strawn</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Flegal</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Mei</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>2000 CDC Growth Charts for the United States: methods and development</article-title>. <source>Vital Health Stat 11</source>. <year>2002</year>;<volume>246</volume>:<fpage>1</fpage>–<lpage>190</lpage>.</mixed-citation></ref>
<ref id="pone.0214081.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duke</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Litt</surname> <given-names>IF</given-names></name>, <name name-style="western"><surname>Gross</surname> <given-names>RT</given-names></name>. <article-title>Adolescents’ self-assessment of sexual maturation</article-title>. <source>Pediatrics</source>. <year>1980</year>;<volume>66</volume>(<issue>6</issue>):<fpage>918</fpage>–<lpage>920</lpage>. <object-id pub-id-type="pmid">7454482</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rasmussen</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Wohlfahrt-Veje</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tefre de Renzy-Martin</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hagen</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Tinggaard</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mouritsen</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Validity of self-assessment of pubertal maturation</article-title>. <source>Pediatrics</source>. <year>2015</year>;<volume>135</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1542/peds.2014-0793" xlink:type="simple">10.1542/peds.2014-0793</ext-link></comment> <object-id pub-id-type="pmid">25535262</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref012"><label>12</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Tanner</surname> <given-names>JM</given-names></name>. <source>Growth at adolescence</source>, <edition>2nd Ed</edition>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Blackwell Scientific Publications</publisher-name>. <year>1962</year>.</mixed-citation></ref>
<ref id="pone.0214081.ref013"><label>13</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization (WHO)</collab>. <source>WHO STEPwise approach to surveillance (STEPS): Section 3—Guide to Physical Measurements (Step 2)</source>. <publisher-loc>Geneva</publisher-loc>, <publisher-name>World Health Organization</publisher-name>; <year>2008</year>. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/chp/steps/Part3_Section3.pdf" xlink:type="simple">http://www.who.int/chp/steps/Part3_Section3.pdf</ext-link>. Accessed 10 January 2011.</mixed-citation></ref>
<ref id="pone.0214081.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arslanian</surname> <given-names>SA</given-names></name>. <article-title>Clamp techniques in paediatrics: what have we learned?</article-title> <source>Horm Res</source>. <year>2005</year>;<volume>64</volume>(<issue>Suppl 3</issue>):<fpage>16</fpage>–<lpage>24</lpage>.</mixed-citation></ref>
<ref id="pone.0214081.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sjaarda</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tfayli</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bacha</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Bertolet</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>S</given-names></name>. <article-title>Measuring β-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice?</article-title> <source>Diabetes Care</source>. <year>2013</year>;<volume>36</volume>(<issue>6</issue>):<fpage>1607</fpage>–<lpage>1612</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2337/dc12-1508" xlink:type="simple">10.2337/dc12-1508</ext-link></comment> <object-id pub-id-type="pmid">23275361</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref016"><label>16</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Best</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wolf</surname> <given-names>C</given-names></name>. <source>The SAGE Handbook of Regression Analysis and Causal Inference</source>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>Sage</publisher-name>; <year>2014</year>.</mixed-citation></ref>
<ref id="pone.0214081.ref017"><label>17</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Ghosh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Schucany</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>WB</given-names></name>. <source>Statistics of Quality</source>. <edition>1st ed</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>CRC Press</publisher-name>; <year>1996</year>.</mixed-citation></ref>
<ref id="pone.0214081.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moran</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>DR</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Steinberger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Prineas</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Luepker</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Insulin resistance during puberty: results from clamp studies in 357 Children</article-title>. <source>Diabetes</source>. <year>1999</year>;<volume>48</volume>(<issue>10</issue>):<fpage>2039</fpage>–<lpage>2044</lpage>. <object-id pub-id-type="pmid">10512371</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bacha</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Saad</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gungor</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Janosky</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>SA</given-names></name>. <article-title>Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2003</year>;<volume>88</volume>(<issue>6</issue>):<fpage>2534</fpage>–<lpage>2540</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2002-021267" xlink:type="simple">10.1210/jc.2002-021267</ext-link></comment> <object-id pub-id-type="pmid">12788850</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brambilla</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bedogni</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Heo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pietrobelli</surname> <given-names>A</given-names></name>. <article-title>Waist circumference-to-height ratio predicts adiposity better than body mass index in children and adolescentes</article-title>. <source>Int J Obes (Lond)</source>. <year>2013</year>;<volume>37</volume>(<issue>7</issue>):<fpage>943</fpage>–<lpage>946</lpage>.</mixed-citation></ref>
<ref id="pone.0214081.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mokha</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Srinivasan</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Dasmahapatra</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Fernandez</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Bogalusa Heart Study</article-title>. <source>BMC Pediatr</source>. <year>2010</year>;<volume>10</volume>:<fpage>73</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2431-10-73" xlink:type="simple">10.1186/1471-2431-10-73</ext-link></comment> <object-id pub-id-type="pmid">20937123</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeLong</surname> <given-names>ER</given-names></name>, <name name-style="western"><surname>DeLong</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Clarke-Pearson</surname> <given-names>DL</given-names></name>. <article-title>Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</article-title>. <source>Biometrics</source>. <year>1988</year>;<volume>44</volume>(<issue>3</issue>):<fpage>837</fpage>–<lpage>845</lpage>. <object-id pub-id-type="pmid">3203132</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantovani</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Rocha</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>Magalhães</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Barbosa</surname> <given-names>IG</given-names></name>, <name name-style="western"><surname>Teixeira</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Simões E Silva</surname> <given-names>AC</given-names></name>. <article-title>Early changes in adipokines from overweight to obesity in children and adolescents</article-title>. <source>J Pediatr (Rio J)</source>. <year>2016</year>;<volume>92</volume>(<issue>6</issue>):<fpage>624</fpage>–<lpage>630</lpage>.</mixed-citation></ref>
<ref id="pone.0214081.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scherer</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Fogliano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baldini</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lodish</surname> <given-names>HF</given-names></name>. <article-title>A novel serum protein similar to C1q, produced exclusively in adipocytes</article-title>. <source>J Biol Chem</source>. <year>1995</year>;<volume>270</volume>(<issue>45</issue>):<fpage>26746</fpage>–<lpage>26749</lpage>. <object-id pub-id-type="pmid">7592907</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kadowaki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yamauchi</surname> <given-names>T</given-names></name>. <article-title>Adiponectin and adiponectin receptors</article-title>. <source>Endocr Rev</source>. <year>2005</year>;<volume>26</volume>(<issue>3</issue>):<fpage>439</fpage>–<lpage>451</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/er.2005-0005" xlink:type="simple">10.1210/er.2005-0005</ext-link></comment> <object-id pub-id-type="pmid">15897298</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yadav</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kataria</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Saini</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Yadav</surname> <given-names>A</given-names></name>. <article-title>Role of leptin and adiponectin in insulin resistance</article-title>. <source>Clin Chim Acta</source>. <year>2013</year>;<volume>417</volume>:<fpage>80</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cca.2012.12.007" xlink:type="simple">10.1016/j.cca.2012.12.007</ext-link></comment> <object-id pub-id-type="pmid">23266767</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weiss</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dufour</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Groszmann</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Petersen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Dziura</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Taksali</surname> <given-names>SE</given-names></name>, <etal>et al</etal>. <article-title>Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2003</year>;<volume>88</volume>(<issue>5</issue>):<fpage>2014</fpage>–<lpage>2018</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jc.2002-021711" xlink:type="simple">10.1210/jc.2002-021711</ext-link></comment> <object-id pub-id-type="pmid">12727947</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bush</surname> <given-names>NC</given-names></name>, <name name-style="western"><surname>Darnell</surname> <given-names>BE</given-names></name>, <name name-style="western"><surname>Oster</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Goran</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>Gower</surname> <given-names>BA</given-names></name>. <article-title>Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents</article-title>. <source>Diabetes</source>. <year>2005</year>;<volume>54</volume>(<issue>9</issue>):<fpage>2772</fpage>–<lpage>2778</lpage>. <object-id pub-id-type="pmid">16123368</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hung</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Sundell</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Egbert</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Siew</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Shintani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ellis</surname> <given-names>CD</given-names></name>, <etal>et al</etal>. <article-title>A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic hemodialysis patients</article-title>. <source>Clin J Am Soc Nephrol</source>. <year>2011</year>;<volume>6</volume>(<issue>4</issue>):<fpage>767</fpage>–<lpage>774</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2215/CJN.08070910" xlink:type="simple">10.2215/CJN.08070910</ext-link></comment> <object-id pub-id-type="pmid">21441124</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Makni</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Moalla</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lac</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Aouichaoui</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cannon</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Elloumi</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The homeostasis model assessment-adiponectin (HOMA-AD) is the most sensitive predictor of insulin resistance in obese children</article-title>. <source>Ann Endocrinol (Paris)</source>. <year>2012</year>;<volume>73</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
<ref id="pone.0214081.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suprasongsin</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Danadian</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>S</given-names></name>. <article-title>Hyperglycemic clamp: A single experiment to simultaneously assess insulin secretion and insulin sensitivity in children [dagger] 420</article-title>. <source>Pediatr Res</source>. <year>1997</year>;<volume>41</volume>:<fpage>72</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1203/00006450-199704001-00440" xlink:type="simple">10.1203/00006450-199704001-00440</ext-link></comment></mixed-citation></ref>
<ref id="pone.0214081.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gungor</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Saad</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Janosky</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Arslanian</surname> <given-names>S</given-names></name>. <article-title>Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents</article-title>. <source>J Pediatr</source>. <year>2004</year>;<volume>144</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpeds.2003.09.045" xlink:type="simple">10.1016/j.jpeds.2003.09.045</ext-link></comment> <object-id pub-id-type="pmid">14722518</object-id></mixed-citation></ref>
<ref id="pone.0214081.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chavarro</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Watkins</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Afeiche</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Sánchez</surname> <given-names>BN</given-names></name>, <name name-style="western"><surname>Cantonwine</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Validity of self-assessed sexual maturation against physician assessments and hormone levels</article-title>. <source>J Pediatr</source>. <year>2017</year>;<volume>186</volume>:<fpage>172</fpage>–<lpage>178.e3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpeds.2017.03.050" xlink:type="simple">10.1016/j.jpeds.2017.03.050</ext-link></comment> <object-id pub-id-type="pmid">28438374</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>